Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Non-Current Assets (2016)

Neuroone Medical Technologies' Other Non-Current Assets history spans 2 years, with the latest figure at $4277.0 for Q4 2016.

  • For Q4 2016, Other Non-Current Assets rose 132.7% year-over-year to $4277.0; the TTM value through Dec 2016 reached $4277.0, up 132.7%, while the annual FY2016 figure was $4277.0, 132.7% up from the prior year.
  • Other Non-Current Assets reached $4277.0 in Q4 2016 per NMTC's latest filing, roughly flat from $4277.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $4277.0 in Q2 2016 to a low of $1838.0 in Q4 2015.